Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 3,573 | 5,090 | 6,312 | 6,720 | 3,266 |
| Operating Income | -3,573 | -5,090 | -6,312 | -6,720 | -3,266 |
| Interest Expense | 17 | 16 | 9 | 7 | 4 |
| Other Income | 4 | 19 | 8 | -1 | 5 |
| Pre-tax Income | -3,586 | -5,087 | -6,313 | -6,728 | -3,265 |
| Net Income Continuous | -3,586 | -5,087 | -6,313 | -6,728 | -3,265 |
| Net Income | $-3,586 | $-5,087 | $-6,313 | $-6,728 | $-3,265 |
| EPS Basic Total Ops | -1.59 | -2.66 | -3.99 | -5.00 | -2.90 |
| EPS Basic Continuous Ops | -1.59 | -2.66 | -3.99 | -4.99 | -2.90 |
| EPS Diluted Total Ops | -1.59 | -2.66 | -3.99 | -5.00 | -2.90 |
| EPS Diluted Continuous Ops | -1.59 | -2.66 | -3.99 | -4.99 | -2.90 |
| EPS Diluted Before Non-Recurring Items | -1.59 | -2.66 | -4.00 | -5.00 | -2.90 |
| EBITDA(a) | $-3,573 | $-5,090 | $-6,312 | $-6,720 | $-3,266 |